Mast Cells in Acid-induced Intestinal Permeability

NCT02664051 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped Inactive

Conditions

Dyspepsia

Interventions

DRUG: Nalcrom
DRUG: placebo

Sponsor

Universitaire Ziekenhuizen KU Leuven